Quoin Pharmaceuticals Ltd DRC Cash Flow-to-Debt Ratio
Quoin Pharmaceuticals Ltd DRC cash flow-to-debt ratio. Quoin Pharmaceuticals Ltd DRC (QNRX) has a Cash Flow-to-Debt Ratio of -0.40x as of June 2026, meaning its operating cash flow of $-3.21 Million could theoretically repay 0% of its total liabilities ($8.04 Million) in one year. See Quoin Pharmaceuticals Ltd DRC (QNRX) financial flexibility to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Quoin Pharmaceuticals Ltd DRC (2015–2025)
Cash flow-to-debt ratio of Quoin Pharmaceuticals Ltd DRC from 2015 to 2025. Historical debt coverage capacity for Quoin Pharmaceuticals Ltd DRC across 11 annual periods. Also explore Quoin Pharmaceuticals Ltd DRC annual equity growth to track the company's year-over-year net asset growth rate.
Quoin Pharmaceuticals Ltd DRC Cash Flow-to-Debt Ratio by Year (2015–2025)
Quoin Pharmaceuticals Ltd DRC cash flow-to-debt ratio by year from 2015 to 2025. Year-by-year debt coverage analysis for Quoin Pharmaceuticals Ltd DRC. For the full cash flow conversion analysis, see how efficiently does Quoin Pharmaceuticals Ltd DRC generate cash.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.86x | $-13.54 Million | $7.27 Million | ▼ -54.2% |
| 2024 | -1.21x | $-7.86 Million | $6.50 Million | ▲ +0.1% |
| 2023 | -1.21x | $-7.86 Million | $6.51 Million | ▼ -0.5% |
| 2022 | -1.20x | $-8.48 Million | $7.05 Million | ▼ -82.9% |
| 2021 | -0.66x | $-5.72 Million | $8.70 Million | ▼ -292.2% |
| 2020 | -0.17x | $-1.34 Million | $7.99 Million | ▲ +94.5% |
| 2019 | -3.04x | $-5.71 Million | $1.88 Million | ▲ +16.9% |
| 2018 | -3.66x | $-6.57 Million | $1.80 Million | ▼ -143.8% |
| 2017 | -1.50x | $-4.98 Million | $3.32 Million | ▲ +43.9% |
| 2016 | -2.67x | $-3.77 Million | $1.41 Million | ▲ +1.0% |
| 2015 | -2.70x | $-1.98 Million | $735.02K | — |